Phospho-regulation of ASCL1-mediated chromatin opening during cellular reprogramming
Development · 2024-12-15 · 151 (24)
DOI: 10.1242/dev.204329 ↗At a glance
Journal article in Development, published online on 2024-12-12. Written by Roberta Azzarelli and 7 co-authors. Institution: Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK. Major MEDLINE topics: Cellular Reprogramming, Basic Helix-Loop-Helix Proteins, Chromatin. Cited 16 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY 4.0). Funded by: Cancer Research UK, University College London, Medical Research Council.
Abstract (original language)
The proneural transcription factor ASCL1 regulates neurogenesis and drives somatic cell reprogramming into neurons. However, not all cell types can be reprogrammed by ASCL1, raising the questions of what provides competence and how we can overcome barriers to enable directed differentiation. Here, we investigate how levels of ASCL1 and its phosphorylation modulate its activity over progressive lineage restriction of mouse embryonic stem cells. We find that inhibition of ASCL1 phosphorylation enhances reprogramming of both mesodermal and neuroectodermal cells, while pluripotent cells remain refractory to ASCL1-directed neuronal differentiation. By performing RNA-seq and ATAC-seq in neuroectoderm, we find that un(der)phosphorylated ASCL1 causes increased chromatin accessibility at sites proximal to neuronal genes, accompanied by their increased expression. Combined analysis of protein stability and proneural function of phosphomutant and phosphomimetic ASCL1 reveals that protein stability plays only a marginal role in regulating activity, while changes in amino acid charge cannot fully explain enhanced activity of the serine-proline mutant variants of ASCL1. Our work provides new insights into proneural factor activity and regulation, and suggests ways to optimize reprogramming protocols in cancer and regenerative medicine.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.
- Department of Pharmacology, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
- Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK.
ORCID profiles: Roberta Azzarelli, Frances Connor, Jethro Lundie-Brown, Anna Philpott
Funding
- Cancer Research UK
- University College London
- Medical Research Council
- Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge
- Wellcome Trust
- Royal Society
Cite
APA
Azzarelli, R., Gillen, S., Connor, F., Lundie-Brown, J., Puletti, F., Drummond, R., Raffaelli, A., & Philpott, A. (2024). Phospho-regulation of ASCL1-mediated chromatin opening during cellular reprogramming. Development, 151(24). https://doi.org/10.1242/dev.204329
Vancouver
Azzarelli R, Gillen S, Connor F, Lundie-Brown J, Puletti F, Drummond R, et al. Phospho-regulation of ASCL1-mediated chromatin opening during cellular reprogramming. Development. 2024;151(24). doi:10.1242/dev.204329
BibTeX
@article{Azzarelli2024,
author = {Azzarelli, Roberta and Gillen, Sarah and Connor, Frances and Lundie-Brown, Jethro and Puletti, Francesca and Drummond, Rosalind and Raffaelli, Ana and Philpott, Anna},
title = {Phospho-regulation of ASCL1-mediated chromatin opening during cellular reprogramming},
journal = {Development},
year = {2024},
volume = {151},
number = {24},
doi = {10.1242/dev.204329}
}
EUVIMED